Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 11 fludarabine phosphate 9 Whole-Body Irradiation 8 Mycophenolic Acid 7 Busulfan 6 fludarabine 5 Tacrolimus 5 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 Rituximab 4 Biopsy 4 Azacitidine 4 venetoclax 3 apixaban 3 Cyclosporine 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Vancomycin 2 Tretinoin 2 Specimen Handling 2 Sirolimus 2 Methotrexate 2 Lenalidomide 2 Injections 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Etoposide 2 Decitabine 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Tazobactam × Classical hematology × 90 days × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡